This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A streptococcal infection, influenza, chikungunya and dengue, and influenza B among young people.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza, diphtheria, measles, iatrogenic botulism, poliomyelitis, and autochthonous Dengue.
Resistance of Salmonella and Campylobacter to commonly used antimicrobials is frequently observed in humans and animals, reveals a report by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 23-29 January 2023 and includes updates on COVID-19, diphtheriae, influenza, chikungunya, dengue and poliomyelitis.
For 2020, 28 countries reported 1 647 cases of hantavirus infection (0.4 cases per 100 000 population), mainly caused by Puumala virus (98%). During the period 2016–2020, the overall notification rate fluctuated between 0.4 and 1.0 cases per 100 00 population, with no obvious long-term trend.